AptarGroup, Inc. reported $3.93B of revenue over the trailing twelve months, +8.9% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.93B (to Q2 2026). Net income: $363M, trailing twelve months to Q2 2026. Free cash flow: $310M, trailing twelve months to Q2 2026. Operating margin: 12%, trailing twelve months to Q2 2026.

ATRAptarGroup, Inc.

Healthcare

$120.37-9.4% 1Y

$120.37

$111.9452 weeks$145.15

ATR as reported

AptarGroup, Inc. reported $3.93B of revenue over the trailing twelve months, +8.9% on the year before. 11 reported series are charted on this page, each one as filed.

$3.93B

Revenue, trailing twelve months · to Q2 2026 · +8.9% against the twelve months before

Net income: $363M
Net income · −7.2% year on year · trailing twelve months to Q2 2026
Free cash flow: $310M
Free cash flow · −15% year on year · trailing twelve months to Q2 2026
Operating margin: 12%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ATR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.93B	+8.9%	Q2 2026
Net income	$363M	−7.2%	Q2 2026
EPS	$5.54	−4.5%	Q2 2026
Gross margin	36%	n/a	Q2 2026
Operating margin	12%	n/a	Q2 2026
Net margin	9.2%	n/a	Q2 2026
ROE	15%	n/a	Q2 2026
ROA	7.6%	n/a	Q2 2026
ROIC	10%	n/a	Q2 2026
Free cash flow	$310M	−15%	Q2 2026
P/E	21.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.